Germany - Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale
Since 2014, Germany Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale increased 8% year on year. At €2,350,575,277.14 in 2019, the country was ranked number 1 comparing other countries in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale. United Kingdom, Poland and Hungary respectively ranked number 2, 3 and 4 in this ranking. Estonia witnessed the best average annual growth at +11.1% per year, while Netherlands was the worst growing country at -38.7% per year.
Loading...
Date | Euros |
---|---|
2019 | 2,350,575,277.14 |
2018 | 2,432,410,217.00 |
2017 | 1,895,524,013.00 |
2016 | 1,616,379,141.00 |
2015 | 1,608,343,361.00 |
Download all data from 1995 to 2019
How does Germany rank in Sold Production of Medicaments of Alkaloids or Derivatives Thereof Packaged for Retail Sale?
# | 17 Countries | Euros | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
Germany
|
2,350,575,277.14 | 2019 | -3.4 % | +8.0 % | View data |
2 |
#2
United Kingdom
|
195,933,082.68 | 2019 | +2.5 % | -5.9 % | View data |
3 |
#3
Poland
|
142,757,293.70 | 2019 | +13.0 % | -1.1 % | View data |
4 |
#4
Hungary
|
128,523,052.44 | 2019 | +6.3 % | -2.7 % | View data |
5 |
#5
France
|
102,455,978.25 | 2019 | -18.9 % | -0.0 % | View data |